C4 Therapeutics (CCCC) Price to Sales (2020 - 2026)
Powered by 
Analysis
C4 Therapeutics (CCCC) Price to Sales (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.77 Bn | 130.92 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.51 Bn | 77.52 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn |
| 4 | Moderna | 58.20 Bn | 53.06 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.40 Bn | 27.56 Bn | - |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn |
| 10 | C4 Therapeutics | 492.07 Mn | 238.41 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 86.43 |
| Mar 31, 2026 | 44.48 |
| Dec 31, 2025 | 16.80 |
| Sep 30, 2025 | 14.66 |
| Jun 30, 2025 | 15.71 |
| Mar 31, 2025 | 15.69 |
| Dec 31, 2024 | 49.11 |
| Sep 30, 2024 | 26.18 |
| Jun 30, 2024 | 26.48 |
| Mar 31, 2024 | 184.90 |
| Dec 31, 2023 | 86.01 |
| Sep 30, 2023 | 8.28 |
| Jun 30, 2023 | 50.65 |
| Mar 31, 2023 | 40.97 |
| Dec 31, 2022 | 101.23 |
| Sep 30, 2022 | 63.56 |
| Jun 30, 2022 | 26.64 |
| Mar 31, 2022 | 154.52 |
| Dec 31, 2021 | 78.08 |
| Sep 30, 2021 | 255.43 |